How we’re leveraging our technology to help find solutions for the long-term impact of COVID-19

About Caladrius

Caladrius Biosciences, Inc. is a clinical-stage biopharmaceutical company dedicated to the development of cellular therapies designed to reverse, not manage, disease.

News

September 14, 2020
Caladrius Biosciences to Present at the Life Sciences Investor Forum on September 17th

September 10, 2020
Caladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual Forum

September 9, 2020
Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan  

Events

September 1, 2020
LD Micro 500 Virtual Conference

August 13, 2020
Caladrius Biosciences Second Quarter 2020 Financial Results and Business Update Conference Call

June 5, 2020
BioNJ COVID-19 Rapid Fire Research Showcase

Sign up to our e-mail list to receive Caladrius announcements.

Technologies & Capabilities

CD34 Cell Technology

T Regulatory Cell Technology